Last edition
News about "Supriya Lifescience"
Supriya Lifescience Receives US FDA EIR with VAI Status for Lote Parshuram Facility
Supriya Lifescience receives US FDA EIR with VAI classification for its Lote Parshuram facility, closing the February 2026 audit inspection cycle.
Supriya Lifescience | 23/04/2026 | By News Bureau
Supriya Lifescience Secures WHO GMP Certification for Ambernath Facility
The WHO certification for Supriya Lifescience paves way for commercial formulations’ production with INR 500 crore revenue potential.
Supriya Lifescience | 04/10/2025 | By Dineshwori | 344
Supriya Lifescience Inaugurates New 5 MWp Solar Facility in Maharashtra
This initiative is part of the ongoing program in which Supriya Lifesciences is committed to reducing carbon footprint from its operations.
Supriya Lifescience | 20/03/2025 | By Aishwarya | 523
Supriya Lifescience appoints Rajeev Kumar Jain as CEO
He has over 35+ years of rich functional experience in the manufacturing domain of bulk drugs, intermediate and API
Supriya Lifescience | 03/10/2022 | By Sudeep Soparkar | 1128
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy